It is clear
that, beyond dealing with diseases like drug-resistant Gonorrhea, which affects
an estimated 78 million people globally, or TB, which affects 10 million people
worldwide, or even the 1 million+ people in the U.S. who get hospitalized with
Pneumonia annually. Or bioweapons
like Anthrax. Unfortunately, it is hard to discover new antibiotics.
For many analysts , the increasing need for inventory level management and the movement of goods in real time to minimize the lack-of-stock situations are the major reasons for the growth of the market. Increased product availability and reduced inventory costs are also driving the market growth, according to Technavio Research.
Comments
Post a Comment